Publication:
Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease

cris.lastimport.scopus2025-05-08T21:53:46Z
cris.virtual.departmentPediatricsen_US
cris.virtual.departmentPediatrics-NTUHen_US
cris.virtual.departmentPediatricsen_US
cris.virtual.departmentClinical Pharmacyen_US
cris.virtual.departmentPediatrics-NTUHen_US
cris.virtual.departmentPediatricsen_US
cris.virtual.departmentPediatrics-NTUHen_US
cris.virtual.departmentPediatricsen_US
cris.virtual.departmentPediatrics-NTUHen_US
cris.virtual.departmentPediatricsen_US
cris.virtual.departmentPediatrics-NTUHen_US
cris.virtual.departmentPediatricsen_US
cris.virtual.departmentPediatrics-NTUHen_US
cris.virtual.orcid0000-0001-5559-1651en_US
cris.virtual.orcid0000-0002-7074-8087en_US
cris.virtual.orcid0000-0001-8880-7113en_US
cris.virtual.orcid0000-0003-2632-1956en_US
cris.virtual.orcid0000-0002-3043-3873en_US
cris.virtual.orcid0000-0002-6872-4764en_US
cris.virtual.orcid0000-0002-1718-7137en_US
cris.virtualsource.department11e64fcf-3f84-4a46-a467-681ba0d04e2e
cris.virtualsource.department11e64fcf-3f84-4a46-a467-681ba0d04e2e
cris.virtualsource.department40c635f2-6895-4210-84ea-c9797f085fda
cris.virtualsource.department40c635f2-6895-4210-84ea-c9797f085fda
cris.virtualsource.department40c635f2-6895-4210-84ea-c9797f085fda
cris.virtualsource.department0eb36684-03b6-4c1c-add9-6c67bcfd366c
cris.virtualsource.department0eb36684-03b6-4c1c-add9-6c67bcfd366c
cris.virtualsource.departmentb517781e-6a19-4657-9ad1-42ae2aeeb577
cris.virtualsource.department87f1551b-3e2a-4b0d-8957-6cfe754d8710
cris.virtualsource.department2f0ee579-f3b3-40aa-9e4a-38a568cce26b
cris.virtualsource.department2f0ee579-f3b3-40aa-9e4a-38a568cce26b
cris.virtualsource.department759971c2-fb46-4ef0-92e5-5577453b4ccd
cris.virtualsource.department759971c2-fb46-4ef0-92e5-5577453b4ccd
cris.virtualsource.orcid11e64fcf-3f84-4a46-a467-681ba0d04e2e
cris.virtualsource.orcid40c635f2-6895-4210-84ea-c9797f085fda
cris.virtualsource.orcid0eb36684-03b6-4c1c-add9-6c67bcfd366c
cris.virtualsource.orcidb517781e-6a19-4657-9ad1-42ae2aeeb577
cris.virtualsource.orcid87f1551b-3e2a-4b0d-8957-6cfe754d8710
cris.virtualsource.orcid2f0ee579-f3b3-40aa-9e4a-38a568cce26b
cris.virtualsource.orcid759971c2-fb46-4ef0-92e5-5577453b4ccd
dc.contributor.authorLiu M.-Y.en_US
dc.contributor.authorLiu H.-M.en_US
dc.contributor.authorWu C.-H.en_US
dc.contributor.authorChang C.-H.en_US
dc.contributor.authorHuang G.-J.en_US
dc.contributor.authorCHUN-AN CHENen_US
dc.contributor.authorSHUENN-NAN CHIUen_US
dc.contributor.authorCHUN-WEI LUen_US
dc.contributor.authorMING-TAI LINen_US
dc.contributor.authorLUAN-YIN CHANGen_US
dc.contributor.authorJOU-KOU WANGen_US
dc.contributor.authorMEI-HWAN WUen_US
dc.creatorLiu M.-Y.;Liu H.-M.;Wu C.-H.;Chang C.-H.;Huang G.-J.;Chen C.-A.;Chiu S.-N.;Chun-Wei Lu;Lin M.-T.;Chang L.-Y.;Wang J.-K.;Wu M.-H.
dc.date.accessioned2020-12-09T09:01:03Z
dc.date.available2020-12-09T09:01:03Z
dc.date.issued2017
dc.description.abstractBackground: Kawasaki disease (KD) is an acute systemic vasculitis that occurs in children and may lead to cardiovascular morbidity and mortality. Progressive coronary dilatation for at least 2 months is associated with worse late coronary outcomes in patients with KD having medium or giant aneurysms. However, the risk factors and occurrence of progressive coronary dilatation in patients with KD but without medium or giant aneurysms have been insufficiently explored. Methods: We retrospectively enrolled 169 patients with KD from a tertiary medical center in Taiwan during 2009-2013. Medical records of all patients were reviewed. Echocardiography was performed during the acute KD phase and at 3-4 weeks, 6-8 weeks, 6 months, and 12 months after KD onset. Progressive coronary dilatation was defined as the progressive enlargement of coronary arteries on three consecutive echocardiograms. Logistic regression analysis was conducted to evaluate the potential risk factors for coronary aneurysms and progressive coronary dilatation. Results: Of a total of 169 patients with KD, 31 (18.3%) had maximal coronary Z-scores of ? + 2.5 during the acute KD phase, 16 (9.5%; male/female: 9/7) had coronary aneurysms at 1 month after KD onset, and 5 (3.0%) satisfied the definition of progressive coronary dilatation. Multivariate logistic regression analysis revealed that an initial maximal coronary Z-score of ? + 2.5 [odds ratio (OR): 5.24, 95% confidence interval (CI): 1.31-21.3, P = 0.020] and hypoalbuminemia (OR: 4.83, 95% CI: 1.11-20.9, P = 0.035) were independent risk factors for coronary aneurysms and were significantly associated with progressive coronary dilatation. However, the association between intravenous immunoglobulin unresponsiveness and the development of coronary aneurysms at 1 month after KD onset didn't reach the level of significance (P = 0.058). Conclusions: In the present study, 3% (5/169) of patients with KD had progressive coronary dilatation, which was associated with persistent coronary aneurysms at 1 year after KD onset. Initial coronary dilatation and hypoalbuminemia were independently associated with the occurrence of progressive coronary dilatation. Therefore, such patients may require intensive cardiac monitoring and adjuvant therapies apart from immunoglobulin therapies. ? 2017 The Author(s).
dc.identifier.doi10.1186/s12887-017-0895-8
dc.identifier.issn1471-2431
dc.identifier.pmid28587647
dc.identifier.scopus2-s2.0-85020172292
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85020172292&doi=10.1186%2fs12887-017-0895-8&partnerID=40&md5=0c209f444cd9aa54620e1945bffe66b4
dc.identifier.urihttps://scholars.lib.ntu.edu.tw/handle/123456789/525254
dc.publisherBioMed Central Ltd.
dc.relation.ispartofBMC Pediatrics
dc.relation.journalissue1
dc.relation.journalvolume17
dc.relation.pages139
dc.subject.classification[SDGs]SDG3
dc.subject.otherimmunoglobulin; adjuvant therapy; Article; cardiovascular risk; child; controlled study; coronary artery aneurysm; coronary artery dilatation; disease association; disease course; drug response; echocardiography; female; human; hypoalbuminemia; immune response; immunotherapy; infant; major clinical study; male; medical record review; mucocutaneous lymph node syndrome; patient monitoring; preschool child; risk assessment; single drug dose; Taiwan; tertiary care center; complication; coronary artery aneurysm; coronary blood vessel; diagnostic imaging; disease exacerbation; follow up; lesions and defects; mucocutaneous lymph node syndrome; odds ratio; pathology; retrospective study; risk factor; statistical model; Child, Preschool; Coronary Aneurysm; Coronary Vessels; Dilatation, Pathologic; Disease Progression; Echocardiography; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Male; Mucocutaneous Lymph Node Syndrome; Odds Ratio; Retrospective Studies; Risk Factors
dc.titleRisk factors and implications of progressive coronary dilatation in children with Kawasaki diseaseen_US
dc.typejournal articleen
dspace.entity.typePublication

Files